Giuseppe Giannini Selected Research

ST1646

11/2005

Biological and molecular properties of a new alpha(v)beta3/alpha(v)beta5 integrin antagonist.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giuseppe Giannini Research Topics

Disease

57	Neoplasms (Cancer) 10/2022 - 02/2002
11	Colorectal Neoplasms (Colorectal Cancer) 02/2022 - 04/2004
9	Carcinoma (Carcinomatosis) 01/2019 - 03/2003
9	Neuroblastoma 01/2018 - 02/2002
6	Breast Neoplasms (Breast Cancer) 12/2020 - 12/2003
6	Ovarian Neoplasms (Ovarian Cancer) 01/2019 - 12/2003
5	Carcinogenesis 06/2021 - 04/2004
5	Neoplasm Metastasis (Metastasis) 12/2018 - 04/2005
4	Microsatellite Instability 01/2022 - 05/2003
3	Colonic Neoplasms (Colon Cancer) 01/2021 - 01/2005
3	Leukemia 07/2007 - 05/2003
2	Medulloblastoma 11/2020 - 11/2019
2	Multiple Myeloma 01/2020 - 01/2016
2	Melanoma (Melanoma, Malignant) 01/2020 - 03/2003
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2018 - 12/2011
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2018 - 03/2015
2	Lung Neoplasms (Lung Cancer) 03/2015 - 01/2015
1	Chromosomal Instability (Chromosome Stability) 01/2022
1	Adenocarcinoma of Lung 01/2021
1	Male Breast Neoplasms (Male Breast Cancer) 08/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019
1	Triple Negative Breast Neoplasms 01/2019
1	Osteolysis 01/2016
1	Atherosclerosis 01/2016

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 10/2022 - 02/2003
8	heparanaseIBA 12/2020 - 04/2005
5	DNA (Deoxyribonucleic Acid)IBA 12/2020 - 02/2003
5	Histone Deacetylase InhibitorsIBA 01/2019 - 07/2012
5	Pharmaceutical PreparationsIBA 11/2018 - 05/2003
4	Biological ProductsIBA 05/2014 - 11/2005
3	Calcibiotic Root Canal SealerIBA 01/2022 - 01/2005
3	roneparstatIBA 01/2020 - 01/2016
3	Estrogen ReceptorsIBA 01/2019 - 04/2012
3	NucleotidesIBA 01/2019 - 04/2004
3	ErbB Receptors (EGF Receptor)IBA 06/2018 - 12/2003
3	RetinoidsIBA 11/2015 - 02/2002
3	Cisplatin (Platino)FDA LinkGeneric 03/2015 - 07/2005
3	Biomarkers (Surrogate Marker)IBA 10/2014 - 01/2012
3	nutlin 3IBA 01/2012 - 01/2011
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2009 - 02/2002
2	Bevacizumab (Avastin)FDA Link 02/2022 - 01/2013
2	olaparibIBA 10/2021 - 02/2014
2	Cetuximab (Erbitux)FDA Link 01/2021 - 08/2018
2	Hydroxamic Acids (Hydroxamic Acid)IBA 01/2021 - 02/2015
2	LigandsIBA 11/2019 - 01/2006
2	Estrogens (Estrogen)FDA Link 08/2019 - 08/2009
2	Monoclonal AntibodiesIBA 01/2019 - 01/2019
2	Histones (Histone)IBA 01/2019 - 04/2016
2	AvidinIBA 11/2018 - 01/2018
2	CamptothecinIBA 11/2018 - 01/2010
2	AmidesIBA 08/2018 - 01/2010
2	Tyrosine Kinase InhibitorsIBA 06/2018 - 01/2015
2	AnticoagulantsIBA 01/2017 - 01/2016
2	Heparin (Liquaemin)FDA LinkGeneric 01/2017 - 01/2016
2	Integrin alphaVIBA 01/2010 - 01/2006
2	HMGA ProteinsIBA 10/2005 - 09/2005
2	Poly TIBA 12/2004 - 04/2004
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Cell-Free Nucleic AcidsIBA 11/2021
1	MK-8776IBA 10/2021
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2021
1	AntibodiesIBA 01/2021
1	Circulating Tumor DNAIBA 01/2021
1	PolyaminesIBA 12/2020
1	Co-Repressor ProteinsIBA 11/2020
1	Phenformin (Fenformin)IBA 11/2020
1	Therapeutic UsesIBA 11/2020
1	Hypoglycemic Agents (Hypoglycemics)IBA 11/2020
1	BiguanidesIBA 11/2020
1	Hormones (Hormone)IBA 08/2019
1	TenascinIBA 01/2019
1	Caspase 3 (Caspase-3)IBA 01/2019
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2019
1	Trastuzumab (Herceptin)FDA Link 01/2019
1	Radioisotopes (Radionuclides)IBA 01/2019
1	EnzymesIBA 01/2019
1	TubulinIBA 01/2019
1	Immunoconjugates (Immunoconjugate)IBA 01/2019
1	ImmunosorbentsIBA 01/2019
1	ST 1481 (Gimatecan)IBA 11/2018
1	PlatinumIBA 07/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018
1	Glycoproteins (Glycoprotein)IBA 01/2018
1	Biotin (Vitamin H)FDA Link 01/2018
1	6- (4- hydroxyphenyl)- 2- thioxo- 2,3- dihydro- 4(1H)- pyrimidinoneIBA 01/2018
1	8-hydroxyguanineIBA 06/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2017
1	Oxidants (Oxidizing Agents)IBA 02/2017
1	PeroxiredoxinsIBA 02/2017
1	metaperiodate (periodate)IBA 01/2017
1	BorohydridesIBA 01/2017
1	ChromatinIBA 01/2017
1	Small Interfering RNA (siRNA)IBA 01/2017

Therapy/Procedure

26	Therapeutics 10/2021 - 05/2003
3	Drug Therapy (Chemotherapy) 10/2021 - 01/2013
2	Precision Medicine 06/2021 - 01/2019
2	Combined Modality Therapy 01/2012 - 01/2011
1	Immunotherapy 01/2022
1	Continuity of Patient Care 01/2019
1	Ligation 01/2019